Iconovo

ST:ICO Sweden Medical Devices
Market Cap
$5.34 Million
Skr59.96 Million SEK
Market Cap Rank
#31162 Global
#459 in Sweden
Share Price
Skr1.13
Change (1 day)
-1.74%
52-Week Range
Skr1.04 - Skr2.96
All Time High
Skr95.00
About

Iconovo AB (publ) develops inhaled medicinal products in Sweden. The company offers ICOres, a multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler; and ICOone nasal single-dose dry powder inhaler for nasal use. It serves generic companies. The company has a collaboration agreeme… Read more

Iconovo - Asset Resilience Ratio

Latest as of December 2025: 3.76%

Iconovo (ICO) has an Asset Resilience Ratio of 3.76% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
Skr4.93 Million
Cash + Short-term Investments
Total Assets
Skr131.08 Million
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Iconovo's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Iconovo's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Skr0.00 0%
Short-term Investments Skr4.93 Million 3.76%
Total Liquid Assets Skr4.93 Million 3.76%

Asset Resilience Insights

  • Limited Liquidity: Iconovo maintains only 3.76% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Iconovo Industry Peers by Asset Resilience Ratio

Compare Iconovo's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
Medical Devices 0.01%
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
Medical Devices 0.26%
Double Medical Technology Inc
SHE:002901
Medical Devices 7.79%
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
Medical Devices 6.64%
Shinhung
KO:004080
Medical Devices 4.17%
UMediC Group Berhad
KLSE:0256
Medical Devices 1.48%
Osang Healthcare Co.,Ltd
KQ:036220
Medical Devices 9.34%
HansBiomed Corporation
KQ:042520
Medical Devices 9.13%

Annual Asset Resilience Ratio for Iconovo (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Iconovo.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 3.76% Skr4.93 Million Skr131.08 Million +0.28pp
2024-12-31 3.48% Skr5.07 Million Skr145.69 Million -14.75pp
2023-12-31 18.22% Skr23.34 Million Skr128.08 Million +7.14pp
2022-12-31 11.09% Skr13.45 Million Skr121.27 Million -52.82pp
2021-12-31 63.91% Skr94.94 Million Skr148.54 Million +2.86pp
2020-12-31 61.05% Skr61.69 Million Skr101.04 Million -17.33pp
2019-12-31 78.38% Skr89.16 Million Skr113.75 Million +5.41pp
2018-12-31 72.97% Skr53.05 Million Skr72.70 Million +19.58pp
2017-12-31 53.39% Skr22.48 Million Skr42.10 Million -3.99pp
2016-12-31 57.39% Skr11.54 Million Skr20.11 Million --
pp = percentage points